JAK2 and cancer: Mechanistically, TSG-6-induced EMT depends on the TSG-6-CD44-ERK axis in cancer cells in an autocrine manner; however, TSG-6 derived from CRC cells activates CAFs via JAK2-STAT3 signaling in a paracrine manner (Figure 8).